Company Overview and News

 
WCB Resources and GBM Resources merger to create a substantial gold development and exploration group

2017-02-16 marketwired
WCB Resources Ltd. (TSX VENTURE:WCB) and GBM Resources Ltd. (ASX:GBZ) are pleased to jointly announce that they have executed a binding HOA to merge the two companies which is to be structured as an Arrangement Agreement under Canadian law . Each WCB shareholder at the record date will receive 8 ordinary shares of GBM for each common share of WCB they hold in consideration for the transfer of those WCB shares to GBM (Merger).
Upvote Downvote

 
STI closes 0.02% higher at 2,735.91

2016-06-27 theedgemarkets
At 5.04pm, the benchmark Straits Times Index rose 0.52 points or 0.02% to 2,735.91. In the broader market, 949.3 million shares valued at $1.13 billion were traded. 205 stocks sunk into the red while 160 ended in the black.
Upvote Downvote

 
Anchor Resources to acquire Malaysian granite producer for $100 mil

2016-06-27 theedgemarkets
SINGAPORE (June 27): Anchor Resources is acquiring all the issued shares of GCT Manufacturing Sdn Bhd, for a consideration of $100 million, to be satisfied in cash and the issue of new Anchor Resources shares.
Upvote Downvote

 
CDL, POSH, Anchor Resources, Frasers Logistics

2016-06-27 theedgemarkets
City Developments says it has confidence in the long-term fundamentals of the UK economy and its own strategy of targeting mainly UK nationals for its residential developments. In a press release after Britain’s decision to leave the EU, CDL says group’ revenue, asset and debt exposure to the UK are 12%, 11% and 12% respectively. “In the last two years, all of our acquisitions in the UK have been outside Central London and a majority of our UK development projects cater to the local market there,” says CDL.
Upvote Downvote

 
Straits Times Index 0.8% lower at 2,935.92 at midday

2016-04-22 theedgemarkets
SINGAPORE (April 22): Singapore stocks were lower at midday on Friday as Asian stocks retreated in the wake of a firmer yen and some disappointing corporate earnings.
Upvote Downvote

 
Straits Times Index up 0.3% at 2,959.24 at midday

2016-04-21 theedgemarkets
SINGAPORE (April 21): Singapore stocks were higher at midday on Thursday, as Asian stocks hit a four-month high, buoyed by a recovery in crude oil prices and better-than-expected US corporate earnings.
Upvote Downvote

 
STI up on 'reassuring' oil price outlook

2016-04-06 straitstimes
A recovery in Brent crude to over US$38 per barrel on the back of Kuwait's assurance that an output freeze by major producers is still likely helped push the benchmark Straits Times Index (STI) up 10.33 points or 0.37 per cent to 2,811.25.
Upvote Downvote

 
The worldwide drought in IPOs

2016-03-27 straitstimes
It has been a long, dry spell in the initial public offering (IPO) market and the drought looks unlikely to end any time soon.
Upvote Downvote

 
Yongnam, YuuZoo, Yeo Hiap Seng, Artivision Technologies, Anchor Resources, Yanlord Land

2016-03-21 theedgemarkets
Specialist civil engineering solutions provider Yongnam Holdings has secured two contracts worth $49.5 million. The two projects include a  structural steelwork sub-contract for a proposed 19-storey mixed-use development which houses the future Outram Community Hospital in Singapore, and a specialist civil engineering sub-contract for the Hong Kong MTR Shatin to Central Line Cross Harbour Tunnel. The two contracts are  expected to have a positive impact on the Group’s financial performance for the year ending Dec 31, 2016.
Upvote Downvote

 
Update: Anchor Resources in downward spiral after debut

2016-03-18 sg.businesstimes.feedsportal
click here to continue to article cliquez ici pour lire l'article weiter zum Artikel clicca qui per visualizzare l'articolo weiter zum Artikel ir a la noticia klik hier om door te gaan naar het artikel Yazıya devam etmek için tıklayın Перейти к статье 继续阅读文章,请点击这里 Tovább a cikkre
Upvote Downvote

 
STI adds 0.81% to 2,903.63 at midday

2016-03-18 theedgemarkets
By 12.32 p.m., the Straits Times Index (STI) rose 0.81% to 2,903.63. Market breadth was positive. Excluding warrants, gainers outnumber decliners 188 to 149.   The STI traded between 2,886.35 and 2,904.51, after opening 0.30% lower at 2,888.75.
Upvote Downvote

 
Anchor Resources debuts on Catalist at 18.2 Singapore cents

2016-03-18 sg.businesstimes.feedsportal
click here to continue to article cliquez ici pour lire l'article weiter zum Artikel clicca qui per visualizzare l'articolo weiter zum Artikel ir a la noticia klik hier om door te gaan naar het artikel Yazıya devam etmek için tıklayın Перейти к статье 继续阅读文章,请点击这里 Tovább a cikkre
Upvote Downvote

 
Gold miner Anchor Resources eyes profit by end of year

2016-03-16 businesstimes.com.sg
MALAYSIAN gold mining group Anchor Resources is hopeful to turn a profit by the end of 2016, despite posting full-year net losses for the past nine years.
Upvote Downvote

 
Outlook's bright, says Malaysian gold miner

2016-03-16 straitstimes
Malaysian gold miner Anchor Resources said its initial public offering (IPO) has been fully subscribed with total proceeds of $7.2 million.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...